Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 4 November 2008, doi:10.1136/bmj.a2363
Cite this as: BMJ 2008;337:a2363
Janice Hopkins Tanne
1 New York
| The first 150 words of the full text of this article appear below. |
Two US senators have asked the non-profit Cardiovascular Research Foundation and Columbia University to clarify their financial relations with manufacturers of cardiac devices such as stents.
Chuck Grassley, senior Republican member of the Senate Committee on Finance, and Herb Kohl, chairman of the Senate Special Committee on Aging, have been investigating links between the medical drug and device industry and influential doctors for several years (BMJ 2008;336:1268, 7 Jun, doi:10.1136/bmj.39598.476250.DB; 2008;336:1327, 14 Jun, doi:10.1136/bmj.39609.364688.DB; 2008;337:a929, 21 Jul, doi:10.1136/bmj.a929; 2008;337:a2088, 16 Oct, doi:10.1136/bmj.a2088; 2008;337:a2200, 21 Oct, doi:10.1136/bmj.a2200).
The senators sent letters to Lee Bollinger, president of Columbia University, and Gregg Stone, chairman of the Cardiovascular Research Foundation, who is also a professor at Columbia. They asked for information by 30 October.
The senators asked Mr Bollinger for information about payments to 22 doctors affiliated to the universitys medical centre. They
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?